The Dow ended Monday, its best monthly performance in three decades, driven by positive indications of the possibility of getting a vaccine to combat the emerging corona virus.
Despite a weak session, on Monday, in which the index decreased by 0.9 percent, the growth it achieved during the month of November reached 12 percent, and thus it achieved the best growth since January 1987.
Monday's session witnessed a partial decline in the "S&P 500" indices (0.5 percent) and "Nasdaq" (0.1 percent).
And November's profits came to revive a sharp decline in financial markets in October, with rising concerns about the lack of a vaccine for the virus and coinciding with the ambiguity of the American election scene
But signs of recovery began to appear after the US elections, which took place on November 3, with the administration of US President Donald Trump the approval of the start of the process of transferring power to the president-elect, Joe Biden, despite Trump's continuing efforts to stab him in the election results, which are in favor of his Democratic opponent.
With the clarity of the political scene, a group of good news came that carried promising results from the trials of "our director" and "Pfizer" vaccines, which alleviated the escalation of the infection rate in the United States.
Moderna’s share rose by 20.2 percent after announcing the submission of an application to health authorities to approve its vaccine in the United States and Europe, after its full trials had proven effective by 94.1 percent.
No comments:
Post a Comment